News

DenovoMatrix binds funding
TU Dresden spinout DenovoMatrix hopes to commercialise a method for effectively cultivating stem cell production.
Sensorygen bites into $50,000
Vertical Venture Partners has joined university venture fund Highlander Venture Fund as an investor in UC Riverside-founded mosquito repellent developer Sensorygen.
Fraunhofer energises Mondas
Industrial analytics spinout Mondas is targeting energy applications and has already started testing at a local solar energy network.
Threatray registers seed funding
Newly-launched Bern University of Applied Sciences spinout Threatray believes its automated malware detection design will improve upon existing approaches.
Mission Bio identifies $30m series B
Agilent and Lam Research participated in a $30m series B for UCSF's DNA analysis spinout Mission Bio, whose existing shareholders include Stanford-StartX Fund.
Moderna loads up $604m in IPO
Investors including co-founder and Harvard professor Timothy Springer scored exits as mRNA therapy developer Moderna floated in the largest biotech IPO of all time.
Zest Tea brews $1m
The tea product supplier has become the fourth business backed by University of Maryland Momentum Fund.
Kets Quantum secures $2.5m
Bristol quantum computer security spinout Kets Quantum Security has won investment from Kx Systems after joining the corporate-backed Teac communications accelerator last year.

News Continued

UCL eyes $126m second fund
University College London hopes to generate as much as $126m for its second Technology Fund, with British Business Bank thought to be among potential limited partners.
Uniseed plants $485,000 in Wildlife Drones
ANU wildlife monitoring spinout Wildlife Drones previously turned to a Csiro-run accelerator to help get its drone-powered animal tracking system off the ground.
Robert Gordon primes accelerator
A total of 28 participants will receive up to $12,650 of capital to support business proposals in spaces including healthcare, fintech, fashion and retail.
Istesso stakes $7.6m
IP Group has poured more funding into Istesso, whose treatment for rheumatoid arthritis traces its roots to an Aberdeen spinout, to drive immuno-metabolism therapies for autoimmune diseases.
Purdue entices Henderson
Scott Henderson has become Purdue Research Foundation’s chief entrepreneurial officer to guide through ecosystems at Purdue projects such as the Discovery Park research district.
Axelspace explores $23m series B round
UTokyo Innovation Platform has backed a $22.8m investment round for Axelspace that will fund the launch of the Tokyo spinout's latest satellite.

Editor's Picks

Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Opportunities and challenges abound at PraxisAuril conference
PraxisAuril's spring conference continues to go from strength to strength, with one in three delegates a first-time attendant.
test reg

Login